Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 7/17/2024 | Speculative Buy | Canaccord Genuity | ||
| 4/5/2024 | $2.25 → $2.75 | Neutral | Alliance Global Partners | |
| 3/20/2024 | Outperform → Perform | Oppenheimer | ||
| 2/9/2024 | Hold → Buy | Canaccord Genuity | ||
| 5/10/2023 | $4.25 → $4.75 | Hold → Buy | Craig Hallum | |
| 4/4/2023 | Underperform → Mkt Perform | Bernstein | ||
| 11/2/2022 | $3.90 | Mkt Perform | Bernstein | |
| 11/2/2022 | $3.00 | Mkt Perform | Bernstein |
Canaccord Genuity resumed coverage of SNDL Inc. with a rating of Speculative Buy
Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously
Oppenheimer downgraded GrowGeneration from Outperform to Perform
Under the new license, Aurora may also cultivate an approved additional product, and plans to expand their offerings to the rapidly growing German patient base. Aurora will also receive a dedicated R&D license, allowing for the trial of up to seven additional novel cultivars at the company's local EU GMP facility in Leuna, Germany.
California's Glass House Reappoints Board Member As Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 for its 19th edition, gathering top CEOs, investors investors and leaders in the cannabis industry, let’s scroll through the latest leadership changes in the space. Get your tickets now before prices surge by following this link. Long Beach, California-based vertically-integrated cannabis company Glass House Brands Inc. (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX:GLASF) (OTCQX:GHBWF) announced last week the reappointment of Hector De La Torre to its board of directors. De La Torre previously served as an original member of the board until 2023. At the time, he s
GrowGeneration Corp. (NASDAQ:GRWG), one of the nation’s top providers of hydroponic and organic gardening products, announced certain preliminary unaudited results Monday for the second quarter of 2024, alongside a strategic restructuring plan aimed at boosting profitability. The company’s net revenue is projected to surpass $53 million, marking a 10.6% increase from the previous quarter’s $47.9 million. Restructuring Plan Targets $12 Million Savings The restructuring plan is designed to save approximately $12 million over the next year. Key areas of focus include enhancing proprietary brands, digital transformation and streamlining operations. GrowGeneration aims for proprietary brand
4 - Leafly Holdings, Inc. /DE (0001785592) (Issuer)
4 - Leafly Holdings, Inc. /DE (0001785592) (Issuer)
4 - Leafly Holdings, Inc. /DE (0001785592) (Issuer)
SC 13G/A - GrowGeneration Corp. (0001604868) (Subject)
SC 13D/A - IGC Pharma, Inc. (0001326205) (Subject)
SC 13D - IGC Pharma, Inc. (0001326205) (Subject)
Storz & Bickel net revenue increased 32% year-over-year in Q2 FY2025 Continued growth across medical cannabis businesses, with net revenue increasing year-over-year by 16% in Canada and 12% in international markets Further improved balance sheet with early prepayment reducing senior secured term loan by US$100MM SMITHS FALLS, ON, Nov. 8, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the second quarter ended September 30, 2024 ("Q2 FY2025"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
Delivered Q3 2024 revenue of $8.4 million Reported net loss of $1.1 million and adjusted EBITDA 1 of $0.4 million Leafly Holdings, Inc. ("Leafly" or "the Company") (NASDAQ:LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its third quarter ended September 30, 2024. "With two consecutive quarters of positive adjusted EBITDA and a retail business that has largely reached a point of stabilization, we're poised to capitalize on the growth opportunities ahead," said Leafly CEO Yoko Miyashita. "We'll continue our laser focus on building a lean and efficient business operation to capitalize on the stabilizing revenu
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a lifestyle and consumer packaged goods company, announces the launch of "Men's Health on Tap," a new podcast series hosted by distinguished doctors, Dr. John P. Sfakianos, MD, Associate Professor, Department of Urology at the Icahn School of Medicine, and Dr. Steven A. Kaplan, MD, Professor, Department of Urology at the Icahn School of Medicine. The podcast aims to break down stigmas around men's health and invite listeners to an open conversation about important men's health topics. "Men's Health on Tap" is a conversational podcast that covers a wide range of topics, including mental healt
PATCHOGUE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and subsidiary of Tilray Brands, (NASDAQ:TLRY, TSX:TLRY), is proud to announce the continuation of its men's health awareness campaign in support of Movember. The month shines a light on key men's health issues—mental health, prostate cancer, and testicular cancer—encouraging open conversations and proactive engagement. To honor the initiative, Blue Point Brewing announced the special release of its classic double IPA, Big Mo, available at our brewery and retailers in Long Island, New York. This hazy double IPA, featuring prominent mosaic hops and an ABV of 8.0%, proud
SMITHS FALLS, ON, Sept. 25, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce today the voting results from its annual general meeting of shareholders held on September 24, 2024 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 1, 2024 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of the direc
Shareholders now have until September 24, 2024 at 9:00 a.m. (Eastern Time) to submit votes to help ensure a quorum is achieved Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at [email protected] SMITHS FALLS, ON, Sept. 20, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) announced today that it has extended the deadline for the submission of proxies related to its upcoming annual general meeting of shareholders (the "Meeting") to September 24, 2024 at 9:00 a.m. (Eastern time). The Meeting will be held later the same day, at 1:00 p.m.
4 - IGC Pharma, Inc. (0001326205) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
10-Q - Leafly Holdings, Inc. /DE (0001785592) (Filer)
8-K - Canopy Growth Corp (0001737927) (Filer)
10-Q - Canopy Growth Corp (0001737927) (Filer)
Storz & Bickel net revenue increased 32% year-over-year in Q2 FY2025 Continued growth across medical cannabis businesses, with net revenue increasing year-over-year by 16% in Canada and 12% in international markets Further improved balance sheet with early prepayment reducing senior secured term loan by US$100MM SMITHS FALLS, ON, Nov. 8, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the second quarter ended September 30, 2024 ("Q2 FY2025"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210%Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical CannabisRe-Affirms Target of Positive Free Cash Flow1 in the Quarter Ending December 31, 2024Maintains Strong Balance Sheet with ~$152 Million of Cash and a Debt-Free Cannabis Business2EDMONTON, AB, Nov. 6, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter fiscal 2025.
The Company reports record Gross Margin and positive Cash Flow and Free Cash Flow CALGARY, AB, Nov. 5, 2024 /CNW/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the third quarter ended September 30, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com. The Company will hold a conference call and webcast presentation at 10:00 a.m. EST (8:00 a.m. MST) o